Vim is a middleware platform for healthcare, founded in 2015 and headquartered in the United States. It aims to address the challenge of siloed and disconnected clinical data and workflows in the healthcare industry. The company's slogan "Vim is a point-of-care connection platform that connects data to enhanced workflows directly in provider EHRs" reflects its core mission. Vim's platform offers a flexible and scalable cloud-based solution, enabling the delivery of data and patient insights at the point of care. The company's last investment of $35.20M came as a Series B funding on 05 May 2021, with notable investors including GreatPoint Ventures, Anthem Venture Partners, Optum Ventures, Frist Cressey Ventures, Premera Blue Cross, Walgreens Boots Alliance, Elevance Health, and Sequoia Capital. This reflects investor confidence in Vim's innovative approach to transforming healthcare delivery. Vim's focus on powering affordable, high-quality healthcare through seamless connectivity is evident in its efforts to empower providers, reduce administrative burden, and accelerate performance initiatives. The company's collaboration with a network of 2,000+ provider organizations highlights the widespread adoption of its platform. In summary, Vim's middleware platform for healthcare addresses critical challenges within the industry, and its recent Series B investment underscores the confidence of notable investors in the company's mission and potential impact on the future of healthcare delivery.
No recent news or press coverage available for Vim.